AN ACT to amend Tennessee Code Annotated, Title 56 and Title 68, relative to the Tennessee Genomic Security and End Organ Harvesting Act.
If enacted, this law will significantly amend Tennessee Code Annotated by introducing regulations related to genetic sequencing, particularly concerning the use of genetic technology and the handling of genomic data in medical and research facilities. Medical facilities will be prohibited from using genetic sequencers or software produced by foreign adversaries. Furthermore, the bill mandates that all genetic data be stored securely within the United States, thus preventing remote access by adversarial entities. These measures create a framework for the state to assert regulatory control over how genetic information is managed and protected, enhancing patient privacy and security.
House Bill 0395, known as the Tennessee Genomic Security and End Organ Harvesting Act, is a legislative measure aimed at safeguarding genetic information and preventing the practice of forced organ harvesting in Tennessee. The bill seeks to address concerns regarding foreign adversaries, particularly focusing on the practices of the People's Republic of China, which have been accused of conducting organ harvesting on vulnerable populations. By implementing protections for genomic data, the bill intends to reduce the risk of exploitation of Tennessee residents' genetic information by entities from foreign adversaries.
The sentiment surrounding HB 0395 appears to be cautious yet resolute. Proponents of the bill argue that it is a necessary step to protect vulnerable individuals from international exploitation and misuse of their genetic information. They emphasize the importance of being proactive in the face of potential threats posed by foreign adversaries. On the other hand, there are concerns about the implications for medical research and collaboration, particularly on whether such stringent regulations could hinder advancements in healthcare and genetic studies. The discussions reflect a tension between national security interests and the need for ongoing scientific innovation.
Key points of contention regarding House Bill 0395 include concerns from medical professionals and researchers about the potential negative impact on genetic research and healthcare practices. Critics argue that the prohibitions on certain technologies could limit access to leading-edge tools necessary for advancing genomic research. Additionally, there are worries that the broad definitions used in the bill, particularly around what constitutes a 'foreign adversary', may lead to unnecessary restrictions and complicate the operations of health facilities. This debate underscores the need for careful balancing between enhancing security and promoting healthcare advancements.